ADVFN US – Market Content Editor

Ulta Beauty Inc (NASDAQ:ULTA) stock reached a new 52-week high at $496.73, reflecting a 21.52% gain over the past year. The beauty retailer’s robust performance is supported by $11.4 billion in sales over the last twelve months and effective strategic initiatives that have resonated well with consumers. This milestone highlights investor confidence in Ulta’s ability…

Toast Inc (NYSE:TOST) shares surged to a 52-week high of $45.88, marking a key milestone for the company. With an average daily trading volume of 7.22 million shares and a market capitalization of $25.91 billion, Toast has solidified its position as a major player in the tech sector. Over the past year, the stock has…

Boeing Co (NYSE:BA) shares reached a fresh 52-week high, closing at $219.18, with the company’s market capitalization standing at $164.85 billion. Over the past six months, Boeing’s stock gained 27.29%, contributing to a 23.52% increase year-to-date. The surge reflects investor confidence as Boeing continues stabilizing its production and delivery schedules amid a recovering global aviation…

GE Vernova LLC (NYSE:GEV) stock soared to a new all-time high of $536.36, pushing its market capitalization to $144.7 billion. The milestone reflects a staggering 206.56% increase in share price over the past year, signaling strong investor confidence in the company’s growth trajectory and strategic positioning. The surge is backed by solid financials, including 6%…

ProKidney Corp. (NASDAQ:PROK) saw its stock skyrocket 115% following the release of positive topline results from its Phase 2 REGEN-007 clinical trial evaluating rilparencel in patients with chronic kidney disease (CKD) and diabetes. The company, which focuses on late-stage cellular therapies, reported that patients in Group 1 of the trial experienced a dramatic 78% improvement…

Longeveron Inc. (NASDAQ:LGVN) saw its stock climb 23% after receiving clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial of its investigational therapy, laromestrocel, for treating pediatric dilated cardiomyopathy (DCM). The FDA approved Longeveron’s Investigational New Drug (IND) application, allowing the biotech company to move straight into a…

Shares of Cemtrex Inc. (NASDAQ:CETX) rose 2.3% after the company reported that its subsidiary, Vicon Industries, secured a follow-on contract worth over $1.2 million from a large county government in the U.S. Midwest. The order, placed through a global systems integration partner, is part of a broader security modernization effort. It includes Vicon’s advanced camera…

Shares of Novo Nordisk (NYSE:NVO) rose 1% following news that the company has submitted an application to the European Medicines Agency (EMA) to approve a higher dose of its obesity treatment, Wegovy. The new application requests clearance for a 7.2 mg subcutaneous dose of semaglutide, an increase over the currently approved formulation. The submission is…

Shares of Predictive Oncology Inc (NASDAQ:POAI) dropped 4.7% after the company disclosed a standby equity purchase agreement with a Yorkville Advisors Global-managed investment fund. Under the agreement, Predictive Oncology has the option to sell up to $10 million in common stock to YA II PN, LTD, giving the company flexibility over the timing and amount…

Shares of NeOnc Technologies Holdings Inc (NASDAQ:NTHI) surged 8.3% following the announcement of a proposed $50 million investment deal with Quazar Investment aimed at expanding the company’s presence in the Middle East and North Africa (MENA). Under a newly signed non-binding term sheet, NeOnc plans to create NuroMENA Holdings Ltd, a wholly owned entity, which…